- Approval Id
- 263ffffc3e7c6bd7
- Drug Name
- QUPRON TABLETS 250 MG
- Product Name
- QUPRON TABLETS 250 MG
- Approval Number
- SIN09569P
- Approval Date
- 1997-12-05
- Registrant
- ZYFAS PHARMA PTE LTD
- Licence Holder
- ZYFAS PHARMA PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>【DOSAGE AND ADMINISTRATION】</strong></p>
<ol>
<li><p>Usually for adults, administer 250~500mg at meal intervals twice a day. In severe mixed infections, administer up to 750mg twice a day. In acute infections, usually treat for 5 to 10 days. After disappearance of symptoms, further administration is required at least for 3 days.</p></li>
<li><p>In patients with severe renal disorder, it should be administered according to the following dosage and administration.</p>
<img src="/TGIF/Qupron-Table1.png" alt="Qupron Dosage Table 1" /><br><br>
<p>When only the concentration of serum creatinine clearance is known, the patient’s creatinine clearance can be estimated by using the following formulas:</p>
<img src="/TGIF/Qupron-Formula1.png" alt="Qupron Dosage Formula 1" /><br><br>
<p>In patient with severe cardiac failure and infections, 750mg can be administered once, but careful monitoring is required and the ciprofloxacin concentration should be periodically estimated. At that time, the peak serum concentration (obtained 1~2 hours after administration) should range from 2~4mcg/ml.</p></li>
<li><p>Dosage may be adjusted according to causative organisms and severity of symptom.</p></li>
</ol>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>【INDICATIONS】</strong></p>
<ol>
<li><p>Susceptible organisms : E. coli, Shigella, Salmonella, Citrobacter, Klebsiella, Enterobacter, Serratia, hafnia, proteus (Indole positive & negative). Pseudomonas, Neisseria, Acinetobacter, Streptococcus, Chlamydia, Staphylococcus, Corynebacterium, Bacteroides, Clostridium</p></li>
<li><p>Indications<br>
Respiratory infections, infections of oral cavity, teeth and jaw, infections of ear, nose and throat, infections of kidney or urinary passages, genital infections containing gonorrhea, gastrointestinal infections, infection and wound of soft tissue, infections of bone and joint, infections in gynecological and obstetric field, septicemia, cerebromeningitis, peritonitis, ophthalmologic infections and infections in bile secretory duct.</p></li>
</ol>
- Contraindications
- <p><strong>【PRECAUTIONS】</strong></p>
<ol>
<li>Contraindications</li>
<ol class="decimalparen">
<li>Patients previously found hypersensitive to it.</li>
<li>Pregnancy and nursing woman</li>
<li>Children and infants</li>
<li>Patients with hepatic disorder</li>
</ol>
</ol>
- Atc Code
- J01MA02
- Atc Item Name
- ciprofloxacin
- Pharma Manufacturer Name
- ZYFAS PHARMA PTE. LTD.
- Company Detail Path
- /organization/zyfas-pharma-pte-ltd
